Beximco Pharmaceuticals Ltd. GDR (BXP)

Sector:

Pharma and Biotech

35.80p
   
  • Change Today:
    -0.20p
  • 52 Week High: 73.00p
  • 52 Week Low: 35.80p
  • Currency: UK Pounds
  • Shares Issued: 100.04m
  • Volume: 13,370
  • Market Cap: £35.81m
  • RiskGrade: 190

Tuesday broker round-up

By Caoimhe Toman

Date: Tuesday 03 Apr 2018

LONDON (ShareCast) - (ShareCast News) - CMC Markets: Shore Capital Markets upgrades to buy from hold.
Reckitt Benckiser Group: Deutsche Bank reiterates buy.

Astrazeneca: Shore Capital Markets reiterates hold.

Rotork: Citigroup reiterates buy with a target price of 325p.

Rolls Royce Group: Citigroup reiterates buy.

International Personal Finance: Citigroup reiterates buy.

Barclays: JP Morgan reiterates overweight with a target price of 250p.

RPC Group: JP Morgan reiterates overweight with a target price of 1,110p.

GVC Holdings: Barclays reiterates overweight with a target price of 1,210p.

GB Group: Berenberg reiterates buy with a target price of 460p.

Flybe: Numis reiterates hold with a target price of 33p.

Hostelworld: Numis reiterates buy with a target price of 422p.

Beximco Pharmaceuticals: Northland Capital Markets initiates at buy with a target price of 75p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

BXP Market Data

Currency UK Pounds
Price 35.80p
Change Today -0.20p
% Change -0.56 %
52 Week High 73.00p
52 Week Low 35.80p
Volume 13,370
Shares Issued 100.04m
Market Cap £35.81m
RiskGrade 190

BXP Dividends

  Latest Previous
  Final Final
Ex-Div 14-Nov-17 n/a
Paid 18-Jan-18 n/a
Amount 1.25 0.50

Trades for 30-May-2025

Time Volume / Share Price
11:21 4,520 @ 36.00p
11:20 3,850 @ 37.85p
11:15 5,000 @ 37.75p

BXP Key Personnel

Chair Ahmed Sohail Fasiur Rahman

Top of Page